Browse Drug Recalls
942 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 942 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 942 FDA drug recalls in TX.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Nov 12, 2019 | fentaNYL 800 mcg/200 mL (4 mcg/mL) BUPivacaine HCl 0.1667% 333.4 mg/200 mL (1... | Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass par... | Class II | QuVa Pharma, Inc. |
| Nov 12, 2019 | fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg/100 mL (2 mg/m... | Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass par... | Class II | QuVa Pharma, Inc. |
| Nov 12, 2019 | fentaNYL 1250 mcg/250 mL (5 mcg/mL) in 0.9% Sodium Chloride 250 mL Bag Preser... | Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass par... | Class II | QuVa Pharma, Inc. |
| Nov 12, 2019 | fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg/100 mL (2 mg/m... | Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass par... | Class II | QuVa Pharma, Inc. |
| Nov 12, 2019 | fentaNYL 2500 mcg/50 mL (50 mcg/mL) 50 mL bag, Preservative Free, Rx, QuVA Ph... | Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass par... | Class II | QuVa Pharma, Inc. |
| Nov 12, 2019 | fentaNYL 2750 mcg/55 mL (50 mcg/mL) 55 mL Syringe, Preservative Free, Rx, QuV... | Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass par... | Class II | QuVa Pharma, Inc. |
| Nov 12, 2019 | fentaNYL 2000 mcg/100 mL (20 mcg/mL) in 0.9% Sodium Chloride, 100 mL Bag, Pre... | Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass par... | Class II | QuVa Pharma, Inc. |
| Oct 10, 2019 | Lyophilized Human Chorionic Gonadotropin 5,000 USP Units For injection, Rx On... | Lack of Sterility Assurance. | Class II | Innoveix Pharmaceuticals Inc |
| Oct 10, 2019 | Lyophilized Chorionic Gonadotropin 11,000 USP Units for Injection, Rx Only, ... | Lack of Sterility Assurance. | Class II | Innoveix Pharmaceuticals Inc |
| Oct 10, 2019 | Lyophilized Sermorelin w/ GHRP2 3 mg For injection, Rx Only, Compounded by: I... | Lack of Sterility Assurance. | Class II | Innoveix Pharmaceuticals Inc |
| Oct 10, 2019 | Lyophilized Human Chorionic Gonadotropin 5,500 USP Units For injection, Rx On... | Lack of Sterility Assurance. | Class II | Innoveix Pharmaceuticals Inc |
| May 23, 2019 | Human Chorionic Gonadotropin 10,000 IU vials, Rx only Pharm D. Solutions 130... | Lack of Sterility Assurance. | Class II | Pharm D Solutions, LLC |
| May 23, 2019 | Nandrolone Decanoate 200 mg/mL Injectable, 10 mL vials, Rx only, Pharm D. Sol... | Lack of Sterility Assurance. | Class II | Pharm D Solutions, LLC |
| May 23, 2019 | Sermorelin/GHRP-2 & 6 (3-3-3 MG) vials, Pharm D. Solutions 1304 South Loop We... | Lack of Sterility Assurance. | Class II | Pharm D Solutions, LLC |
| May 23, 2019 | B-complex (Thiamine 100mg, Riboflavin 2mg, Niacinamide 100 mg, Pyridoxine 2mg... | Lack of Sterility Assurance. | Class II | Pharm D Solutions, LLC |
| May 23, 2019 | Sermorelin/GHRP-2 9 mg/9 mg vials Pharm D. Solutions 1304 South Loop West, Ho... | Lack of Sterility Assurance. | Class II | Pharm D Solutions, LLC |
| May 23, 2019 | Sermorelin/GHRP-2 &6 (9-9-9 mg) vials, Pharm D. Solutions 1304 South Loop Wes... | Lack of Sterility Assurance. | Class II | Pharm D Solutions, LLC |
| May 23, 2019 | Sermorelin/Ipamorelin 18 mg/15 mg, 10mL vials, Rx only, Pharm D. Solutions 13... | Lack of Sterility Assurance. | Class II | Pharm D Solutions, LLC |
| May 23, 2019 | Testosterone Cyp/Pro 95/5%, 10 mL vials, Rx only, Pharm D. Solutions 1304 S... | Lack of Sterility Assurance. | Class II | Pharm D Solutions, LLC |
| May 23, 2019 | Sermorelin/GHRP-2 &6 (9-9-9-mg) vials, Pharm D. Solutions 1304 South Loop Wes... | Lack of Sterility Assurance. | Class II | Pharm D Solutions, LLC |
| May 23, 2019 | Trimix 30mg/1 mg/10mcg/mL ( 30 mg Papaverine, 1mg phentolamine mesylate, 30 m... | Lack of Sterility Assurance. | Class II | Pharm D Solutions, LLC |
| May 23, 2019 | Lipo MIC-12 (Methylcobalamin, USP 1mg, Methionine USP 15mg, Inositol, FCC 50m... | Lack of Sterility Assurance. | Class II | Pharm D Solutions, LLC |
| May 23, 2019 | Bacteriostatic Water for Injection, 10 mL vials, Pharm D. Solutions 1304 Sout... | Lack of Sterility Assurance. | Class II | Pharm D Solutions, LLC |
| May 23, 2019 | Sermorelin/GHRP-2 9 mg/6 mg vials, Rx only, Pharm D. Solutions 1304 South Loo... | Lack of Sterility Assurance. | Class II | Pharm D Solutions, LLC |
| May 23, 2019 | Testosterone Cypionate 200 mg/mL, in a) 5mL vials and b)10 mL vials, Rx only,... | Lack of Sterility Assurance. | Class II | Pharm D Solutions, LLC |
| May 23, 2019 | Ipamorelin Acetate 9 mg/9mL Injectable vials, Rx only, Pharm D. Solutions 130... | Lack of Sterility Assurance. | Class II | Pharm D Solutions, LLC |
| May 23, 2019 | Human Chorionic Gonadotropin 12,000 IU vials Pharm D. Solutions 1304 South L... | Lack of Sterility Assurance. | Class II | Pharm D Solutions, LLC |
| May 23, 2019 | Testosterone 200 mg/mL, 30 mL vials, Rx only, Pharm D. Solutions 1304 South L... | Lack of Sterility Assurance. | Class II | Pharm D Solutions, LLC |
| May 23, 2019 | Human Chorionic Gonadotropin 5,000 IU vials, Rx only, Pharm D. Solutions 1304... | Lack of Sterility Assurance. | Class II | Pharm D Solutions, LLC |
| Apr 26, 2019 | HYDROmorphone 20 mg/100 mL Injectable Solution, Hydromorphone HCl 20 mg 0.9% ... | Sub-potency | Class II | Advanced Pharma Inc. |
| Apr 15, 2019 | Volumex (Iodinated I 131 Albumin) Injection USP, 25 uCi per 1 mL syringe, Rx ... | Lack of Assurance of Sterility: environmental monitoring report exceeds limits, therefore sterili... | Class II | Iso-Tex Diagnostics, Inc |
| Apr 5, 2019 | Kopi Jantan Tradisional Natural Herbs Coffee, 13g individual packages, Manufa... | Marketed Without An Approved NDA/ANDA: FDA analysis found this product to be tainted with undecla... | Class I | Brian P. Richardson |
| Mar 19, 2019 | Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%... | cGMP Deviations | Class II | Allergan Sales, LLC |
| Mar 13, 2019 | Neostigmine Methylsulfate Injection Solution 5 mg/5mL (1 mg per mL), 5mL Ster... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Mar 13, 2019 | Phenylephrine HCl, 1,200 mcg in 0.9% Sodium Chloride, QS 10 mL Injectable Sol... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Mar 13, 2019 | HYDROmorphone HCl 1 mg in 0.9% Sodium Chloride, QS 5 mL Injectable Solution 1... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Mar 13, 2019 | Heparin 10 Units/10 mL 10 Units in 0.45% Sodium Chloride, QS 10 mL, Injectabl... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Mar 13, 2019 | Phenylephrine HCl, 500 mcg in 0.9% Sodium Chloride, QS 5 mL Injectable Soluti... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Mar 13, 2019 | Midazolam Benzodiazepine 50 mg/50 mL (1 mg/mL) Injectable Solution, Midazolam... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Mar 13, 2019 | Phenylephrine HCl, 800 mcg in 0.9% Sodium Chloride, QS 10 mL Injectable Solut... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Mar 13, 2019 | 2% Lidocaine HCl Injectable Solution, 100 mg/5 mL (20 mg per mL), 5mL Sterile... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Mar 13, 2019 | Glycopyrrolate 0.6 mg/3 mL (0.2 mg per mL) Injectable Solution, 3 mL Sterile ... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Mar 13, 2019 | Phenylephrine HCl, 1 mg in Sterile Water for Injection, QS 10 mL Injectable S... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Mar 13, 2019 | Glycopyrrolate Injectable Solution 1 mg/5 mL (0.2 mg per mL), Sterile single ... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Mar 13, 2019 | fentaNYL 2500 mcg/250 mL Injectable Solution, Fentanyl 0.9% Sodium Chloride, ... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Mar 13, 2019 | Esmolol HCl Injectable Solution 100 mg/10 mL (10 mg per mL)10mL Sterile singl... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Mar 13, 2019 | Phenylephrine HCl, 400 mcg in 0.9% Sodium Chloride, QS 10 mL Injectable Solut... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Mar 13, 2019 | Heparin 5,000 Units/5mL (1,000 Units per mL) Injectable Solution, 5,000 Units... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Mar 13, 2019 | 2% Lidocaine HCl Injectable Solution, 60 mg/3 mL (20 mg per mL), 3mL Sterile ... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Mar 13, 2019 | Phenylephrine HCl, 1 mg in 0.9% Sodium Chloride, QS 10 mL Injectable Solution... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.